ES2187947T3 - Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv. - Google Patents

Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv.

Info

Publication number
ES2187947T3
ES2187947T3 ES98912441T ES98912441T ES2187947T3 ES 2187947 T3 ES2187947 T3 ES 2187947T3 ES 98912441 T ES98912441 T ES 98912441T ES 98912441 T ES98912441 T ES 98912441T ES 2187947 T3 ES2187947 T3 ES 2187947T3
Authority
ES
Spain
Prior art keywords
hiv
hiv1
antigen
procedure
subo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98912441T
Other languages
English (en)
Other versions
ES2187947T5 (es
Inventor
Frederic Donie
Elke Faatz
Barbara Upmeier
Eva Hoess
Eric Saman
Marie-Ange Buyse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26034683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2187947(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19727943A external-priority patent/DE19727943A1/de
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Publication of ES2187947T3 publication Critical patent/ES2187947T3/es
Application granted granted Critical
Publication of ES2187947T5 publication Critical patent/ES2187947T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invención se refiere a un procedimiento para la diagnosis de una infección por HIV por medio de un inmunoensayo que detecta específicamente el antígeno p24 del antígeno HIV, HIV1-subO y/o el antígeno p26 del antígeno HIV2, al menos un anticuerpo contra la zona env del HIV1, HIV1-subO y/o HIV2 y al menos un anticuerpo contra la zona pol y/o gag del HIV1, HIV1-subO y/o HIV2. La invención se refiere además a equipos de reactivos y a tiras de prueba adecuadas para el procedimiento de diagnosis y a los anticuerpos monoclonales contra p24 y la utilización de los mismos.
ES98912441.7T 1997-03-10 1998-03-05 Procedimiento para la detección simultánea de antígenos de HIV y anticuerpos de HIV Expired - Lifetime ES2187947T5 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19709762 1997-03-10
DE19709762 1997-03-10
DE19727943 1997-07-01
DE19727943A DE19727943A1 (de) 1997-03-10 1997-07-01 Verfahren zur simultanen Bestimmung von HIV-Antigenen und HIV-Antikörpern
PCT/EP1998/001235 WO1998040744A1 (de) 1997-03-10 1998-03-05 Verfahren zur simultanen bestimmung von hiv-antigenen und hiv-antikörpern

Publications (2)

Publication Number Publication Date
ES2187947T3 true ES2187947T3 (es) 2003-06-16
ES2187947T5 ES2187947T5 (es) 2014-01-29

Family

ID=26034683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98912441.7T Expired - Lifetime ES2187947T5 (es) 1997-03-10 1998-03-05 Procedimiento para la detección simultánea de antígenos de HIV y anticuerpos de HIV

Country Status (8)

Country Link
US (1) US6593079B1 (es)
EP (1) EP0972198B2 (es)
JP (1) JP3534417B2 (es)
AT (1) ATE228248T1 (es)
AU (1) AU6727798A (es)
CA (1) CA2283058C (es)
ES (1) ES2187947T5 (es)
WO (1) WO1998040744A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004200155C1 (en) * 1999-03-04 2015-07-23 Bionor Immuno As HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
NO311807B1 (no) 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
DE10059720A1 (de) 2000-11-30 2002-06-06 Roche Diagnostics Gmbh Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
FR2882557A1 (fr) * 2005-02-25 2006-09-01 Centre Nat Rech Scient Epitopes de vih et composition pharmaceutique les contenant
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
EP1933145B1 (en) * 2006-12-11 2011-09-28 AraGen Biotechnology Co. Ltd. Rapid immunochromatographic detection by amplification of the colloidal gold signal
WO2009137532A1 (en) * 2008-05-06 2009-11-12 New York Blood Center Antiviral cell penetrating peptides
US20100297607A1 (en) 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
DE3636540A1 (de) 1986-10-27 1988-04-28 Behringwerke Ag Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren
DE3705686C2 (de) 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
DE3853422T2 (de) † 1988-06-09 1995-10-26 Innogenetics Nv HIV-3-Retrovirus und seine Verwendung.
ES2094124T3 (es) 1989-03-09 1997-01-16 Abbott Lab Ensayo-inmunologico de anticuerpos contra hiv.
JP2001504572A (ja) * 1992-04-09 2001-04-03 アボツト・ラボラトリーズ Ｈｉｖ抗原及びｈｉｖ抗体を検出するためのアッセイ
DE4236189A1 (de) 1992-10-27 1994-04-28 Boehringer Mannheim Gmbh Verfahren zur simultanen Bestimmung von Antigenen und Antikörpern
CN1114106C (zh) 1994-07-25 2003-07-09 罗切诊断学有限公司 金属螯合物标记的肽及其制备方法
DE59511054D1 (de) 1994-07-25 2006-08-10 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
ATE214073T1 (de) 1994-07-25 2002-03-15 Roche Diagnostics Gmbh Hapten-markierte peptide

Also Published As

Publication number Publication date
AU6727798A (en) 1998-09-29
WO1998040744A1 (de) 1998-09-17
EP0972198B1 (de) 2002-11-20
EP0972198A1 (de) 2000-01-19
ATE228248T1 (de) 2002-12-15
EP0972198B2 (de) 2013-12-11
JP2001514749A (ja) 2001-09-11
JP3534417B2 (ja) 2004-06-07
CA2283058A1 (en) 1998-09-17
US6593079B1 (en) 2003-07-15
ES2187947T5 (es) 2014-01-29
CA2283058C (en) 2011-09-27

Similar Documents

Publication Publication Date Title
ES2187947T3 (es) Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv.
Clerici et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1
BR0210598A (pt) Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie
CY1108299T1 (el) Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου
ES8700441A1 (es) Metodo de diagnostico de enfermedades y perfeccionamientos en los sistemas de ensayo de sueros
CA2224003A1 (en) Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
Archibald et al. Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection
PT599417E (pt) Metodo para dissociar um imunocomplexo e imunoensaio que o utiliza
DE3854553D1 (de) Verfahren zum schnellen und empfindlichen Nachweis von IgM-Antikörpern gegen retrovirale Antigene.
Roberts et al. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II
EP1016671A3 (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
Tinguely et al. Comparison of a conventional HIV 1/2 line immunoassay with a rapid confirmatory HIV 1/2 assay
Närvänen et al. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection
Arya et al. Recent advances in diagnosis HIV and future prospects
AR011954A1 (es) UN PROCEDIMIENTO PARA EL DIAGNOSTICO DE UNA INFECCION POR HIV MEDIANTE UN INMUNOENSAYO, PROCEDIMIENTO PARA LA DETECCION DE ANTICUERPOS CONTRA HIV,ANTICUERPOS MONOCLONALES CONTRA EL ANTIGENO p24 DEL HIV1, USO DE DICHOS ANTICUERPOS MONOCLONALES, UN KIT DE REACTIVOS PARA LA DETECCION DE UNA
ES2140821T3 (es) Deteccion de la produccion de anticuerpos.
Warren et al. Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in infected individuals grouped according to CD4+ cell levels
ES2058259T5 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
Choppin et al. HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
AR015659A1 (es) Un procedimiento para la deteccion de anticuerpos contra el hiv y antigenos usados en el mismo.
Graham et al. Immunodominant epitopes of HIV-1 p17 and p24
Sommerfelt et al. A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particles
Garland et al. Specific Western blot bands are associated with initial CD4+ lymphocyte counts in human immunodeficiency virus seroconverters
DE3854665D1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.